Literature DB >> 8970584

Melanoma and sun exposure.

J M Elwood1.   

Abstract

The evidence relating cutaneous melanoma in humans to sun exposure was extensively reviewed by the International Association for Research on Cancer (IARC) in 1992. Since then, 10 further epidemiological studies have been published. These are systematically reviewed, in a manner consistent with the IARC Monograph, to provide a definitive update on melanoma epidemiology. As the development of melanoma by sun or ultraviolet exposure is not amenable to experimental testing in humans, and as there is no clearly analogous animal model, the evidence for this association is dependent on epidemiological studies, now numbering 39, involving more than 10,000 subjects. A review of the results from all these studies shows that there is strong evidence for increased risk related to intermittent sun exposure, whereas the relationships with occupation and with total sun exposure are much more variable. There is a strong and consistent association found with a history of sunburn. These results and their implications are discussed.

Entities:  

Mesh:

Year:  1996        PMID: 8970584

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  9 in total

1.  The Usf-1 transcription factor is a novel target for the stress-responsive p38 kinase and mediates UV-induced Tyrosinase expression.

Authors:  M D Galibert; S Carreira; C R Goding
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

2.  Sun exposure, vitamin D receptor polymorphisms FokI and BsmI and risk of multiple primary melanoma.

Authors:  Rochelle Mandelcorn-Monson; Loraine Marrett; Anne Kricker; Bruce K Armstrong; Irene Orlow; Chris Goumas; Susan Paine; Stefano Rosso; Nancy Thomas; Robert C Millikan; Jason D Pole; Javier Cotignola; Cheryl Rosen; Peter A Kanetsky; Julia Lee-Taylor; Colin B Begg; Marianne Berwick
Journal:  Cancer Epidemiol       Date:  2011-05-25       Impact factor: 2.984

3.  p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation.

Authors:  Tamara Terzian; Enrique C Torchia; Daisy Dai; Steven E Robinson; Kazutoshi Murao; Regan A Stiegmann; Victoria Gonzalez; Glen M Boyle; Marianne B Powell; Pamela M Pollock; Guillermina Lozano; William A Robinson; Dennis R Roop; Neil F Box
Journal:  Pigment Cell Melanoma Res       Date:  2010-12       Impact factor: 4.693

4.  Treatment and outcomes of melanoma in acral location in Korean patients.

Authors:  Mi Ryung Roh; Jihyun Kim; Kee Yang Chung
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

Review 5.  The benefits and risks of ultraviolet tanning and its alternatives: the role of prudent sun exposure.

Authors:  Raja K Sivamani; Lori A Crane; Robert P Dellavalle
Journal:  Dermatol Clin       Date:  2009-04       Impact factor: 3.478

6.  Salidroside can target both P4HB-mediated inflammation and melanogenesis of the skin.

Authors:  Xiu-Juan Ding; Zhi-Yuan Zhang; Jing Jin; Jing-Xia Han; Yan Wang; Kai Yang; Yu-Yan Yang; Hong-Qi Wang; Xin-Tong Dai; Cheng Yao; Tao Sun; Cai-Bin Zhu; Hui-Juan Liu
Journal:  Theranostics       Date:  2020-08-13       Impact factor: 11.556

7.  Effect of Sun exposure-induced ferroptosis mechanisms on pathology and potential biological processes of primary melanoma by microarray data analysis.

Authors:  Yakun Gao; Qiang Hou; Rong Guo; Jianghui Ying; Jiachao Xiong; Hua Jiang
Journal:  Front Genet       Date:  2022-09-26       Impact factor: 4.772

8.  Comparison of the Transcriptional Profiles of Melanocytes from Dark and Light Skinned Individuals under Basal Conditions and Following Ultraviolet-B Irradiation.

Authors:  Saioa López; Isabel Smith-Zubiaga; Alicia García de Galdeano; María Dolores Boyano; Oscar García; Jesús Gardeazábal; Conrado Martinez-Cadenas; Neskuts Izagirre; Concepción de la Rúa; Santos Alonso
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

9.  Arg72Pro polymorphism of TP53 gene and the risk of skin cancer: a meta-analysis.

Authors:  Jun Ye; Xiao-Fen Li; Yong-Dong Wang; Ying Yuan
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.